US Physicalrapy Number Of Shares Shorted vs. Current Valuation

USPH Stock  USD 98.76  1.68  1.73%   
Based on the key profitability measurements obtained from US Physicalrapy's financial statements, US Physicalrapy's profitability may be sliding down. It has an above-average probability of reporting lower numbers next quarter. Profitability indicators assess US Physicalrapy's ability to earn profits and add value for shareholders. The US Physicalrapy's current Price To Sales Ratio is estimated to increase to 2.99. The US Physicalrapy's current Days Sales Outstanding is estimated to increase to 62.36. As of now, US Physicalrapy's Interest Income is decreasing as compared to previous years. The US Physicalrapy's current Change To Netincome is estimated to increase to about 39.9 M, while Net Income is projected to decrease to under 20.1 M.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.290.1852
Way Up
Very volatile
Pretax Profit Margin0.0880.0816
Significantly Up
Slightly volatile
For US Physicalrapy profitability analysis, we use financial ratios and fundamental drivers that measure the ability of US Physicalrapy to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well US Physicalrapy utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between US Physicalrapy's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of US Physicalrapy over time as well as its relative position and ranking within its peers.
  

US Physicalrapy's Revenue Breakdown by Earning Segment

Check out World Market Map.
For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.24)
Dividend Share
1.75
Earnings Share
0.88
Revenue Per Share
42.489
Quarterly Revenue Growth
0.12
The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, US Physicalrapy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

US Physicalrapy Current Valuation vs. Number Of Shares Shorted Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining US Physicalrapy's current stock value. Our valuation model uses many indicators to compare US Physicalrapy value to that of its competitors to determine the firm's financial worth.
US Physicalrapy is rated below average in number of shares shorted category among its peers. It is rated below average in current valuation category among its peers reporting about  2,350  of Current Valuation per Number Of Shares Shorted. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the US Physicalrapy's earnings, one of the primary drivers of an investment's value.

USPH Current Valuation vs. Number Of Shares Shorted

Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.

US Physicalrapy

Shares Shorted

 = 

Shorted by Public

+

by Institutions

 = 
682.02 K
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

US Physicalrapy

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
1.6 B
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.

USPH Current Valuation vs Competition

US Physicalrapy is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is at this time estimated at about 239.73 Billion. US Physicalrapy maintains roughly 1.6 Billion in current valuation contributing less than 1% to equities under Health Care industry.

US Physicalrapy Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in US Physicalrapy, profitability is also one of the essential criteria for including it into their portfolios because, without profit, US Physicalrapy will eventually generate negative long term returns. The profitability progress is the general direction of US Physicalrapy's change in net profit over the period of time. It can combine multiple indicators of US Physicalrapy, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income2.8 M2.9 M
Operating Income69.6 M73 M
Net Income37.2 M20.1 M
Income Tax Expense12.2 M7.7 M
Income Before Tax49.4 M31.9 M
Total Other Income Expense Net-20.2 M-19.2 M
Net Income Applicable To Common Shares33.7 M19.8 M
Net Income From Continuing Ops41.9 M42.3 M
Non Operating Income Net Other2.9 M2.3 M
Interest IncomeM3.2 M
Net Interest Income-6.5 M-6.8 M
Change To Netincome38 M39.9 M
Net Income Per Share 1.03  0.92 
Income Quality 2.20  2.20 
Net Income Per E B T 0.30  0.28 

USPH Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on US Physicalrapy. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of US Physicalrapy position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the US Physicalrapy's important profitability drivers and their relationship over time.

Use US Physicalrapy in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if US Physicalrapy position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in US Physicalrapy will appreciate offsetting losses from the drop in the long position's value.

US Physicalrapy Pair Trading

US Physicalrapy Pair Trading Analysis

The ability to find closely correlated positions to US Physicalrapy could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace US Physicalrapy when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back US Physicalrapy - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling US Physicalrapy to buy it.
The correlation of US Physicalrapy is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as US Physicalrapy moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if US Physicalrapy moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for US Physicalrapy can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your US Physicalrapy position

In addition to having US Physicalrapy in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Impulse Thematic Idea Now

Impulse
Impulse Theme
Large corporations operating in retail, broadcasting, energy, airlines and telecom sectors. The Impulse theme has 49 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Impulse Theme or any other thematic opportunities.
View All  Next Launch
When determining whether US Physicalrapy offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of US Physicalrapy's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Us Physicalrapy Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Us Physicalrapy Stock:
Check out World Market Map.
For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
To fully project US Physicalrapy's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of US Physicalrapy at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include US Physicalrapy's income statement, its balance sheet, and the statement of cash flows.
Potential US Physicalrapy investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although US Physicalrapy investors may work on each financial statement separately, they are all related. The changes in US Physicalrapy's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on US Physicalrapy's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.